Project Profile

VX07-950-108: A Phase 3 Study of 2 Dose Regimens of telaprevir in Combination With Peginterferon Alfa 2a (Pegasys) and Ribavirin (Copegus) in Treatment Naïve Subjects with Genotype 1 Chronic Hepatitis C

Keyword Search